Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study
- PMID: 36036675
- DOI: 10.1111/aos.15232
Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study
Abstract
Purpose: To determine the contribution of common and rare genetic variants in age-related macular degeneration (AMD) in a Portuguese population from the Coimbra Eye Study (CES), and the genetic risk score (GRS).
Methods: Participants underwent ophthalmologic examination and imaging. A centralized reading centre performed AMD staging. Genetic sequencing was carried out with the EYE-RISK assay. Sixty-nine single nucleotide polymorphisms (SNPs) were genotyped and tested for association with AMD. Case-control and progression-to-AMD analyses were performed using logistic regression to assess allelic odds ratio (OR) at a 95% confidence interval (CI) for each variant. GRS was calculated for cases/controls and progressors/non-progressors. Cumulative impact of rare variants was compared between cases/controls using logistic regression.
Results: In case-control analysis (237 cases/640 controls) variants associated with risk of disease were: ARMS2 rs10490924, ARMS2_HTRA1 rs3750846, CFH rs35292876, SLC16A8 rs8135665, TGFBR1 rs1626340. Major risk variants ARMS2/HTRA1 rs3750846, CFH rs570618 and C3 rs2230199 had unexpected lower allele frequency (AF), and the highest risk-conferring variant was a rare variant, CFH rs35292876 (OR, 2.668; p-value = 0.021). In progression-to-AMD analysis (137 progressors/630 non-progressors), variants associated with risk of progression were ARMS2 rs10490924, ARMS2_HTRA1 rs3750846, CFH rs35292876. GRS of cases/controls was 1.124 ± 1.187 and 0.645 ± 1.124 (p-value < 0.001), and of progressors/non-progressors was 1.190 ± 1.178 and 0.669 ± 1.141 (p-value < 0.001). Higher proportion of pathogenic rare CFH variants was observed in cases (OR, 9.661; p-value < 0.001).
Conclusions: Both common and rare variants were associated with AMD, but a CFH rare variant conferred the highest risk of disease while three major risk variants had a lower-than-expected AF in our population originary from a geographic region with lower prevalence of AMD. GRS was still significantly higher in AMD patients. Damaging CFH rare variants were cumulatively more common in AMD cases.
Keywords: Coimbra eye study; age-related macular degeneration; common genetic variants; genetic risk score; rare genetic variants; single nucleotide polymorphism.
© 2022 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
References
REFERENCES
-
- Cabral De Guimaraes, T.A., Daich Varela, M., Georgiou, M. & Michaelides, M. (2021) Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions. The British Journal of Ophthalmology, 106, 297-304. https://doi.org/10.1136/bjophthalmol-2020-318452
-
- Cachulo, M.L., Laíns, I., Lobo, C. et al. (2016) Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra eye study - report 2. Acta Ophthalmologica, 94, e442-e453.
-
- Cachulo, M.D.L., Lobo, C., Figueira, J. et al. (2015) Prevalence of age-related macular degeneration in Portugal: The Coimbra eye study - report 1. Ophthalmologica, 233, 119-127.
-
- Colijn, J.M., Buitendijk, G.H.S., Prokofyeva, E., Alves, D., Cachulo, M.L., Khawaja, A.P. et al. (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology, 124, 1753-1763.
-
- Colijn, J.M., Meester-Smoor, M., Verzijden, T., de Breuk, A., Silva, R., Merle, B.M.J. et al. (2021) Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK consortium. Ophthalmology, 128(7), 1039-1049.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
